Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
World Journal of Urology|January 1, 1994
Differential expression of transforming growth factor-beta 1 and beta 3 as well as c-fos mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancerV W Merz, A M Arnold, U E StuderThe Journal of Urology|July 1, 1995
Experience in 100 patients with an ileal low pressure bladder substitute combined with an afferent tubular isoperistaltic segmentU E Studer, H Danuser, V W Merz, et al.The Journal of Urology|January 1, 1996
No evidence of osteopenia 5 to 8 years after ileal orthotopic bladder substitutionA B Tschopp, K Lippuner, P Jaeger, et al.British Journal of Urology|February 1, 1995
Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladderV W Merz, D Marth, R Kraft, et al.Cancer Surveys|January 1, 1991
Experimental oncogene induced prostate cancerT C Thompson, D Kadmon, T L Timme, et al.The Prostate|May 1, 1997
Transforming growth factor-beta 3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinomaV Djonov, R K Ball, S Graf, et al.The Prostate|June 1, 1997
Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutationsA E Mottaz, R Markwalder, M F Fey, et al.Endocrinology|March 1, 1994
Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesisT L Timme, L D Truong, V W Merz, et al.Molecular Endocrinology (Baltimore, Md.)|April 1, 1991
Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progressionV W Merz, G J Miller, T Krebs, et al.Pageof 1